Nuvalent Inc (NUVL)
75.84
-1.13
(-1.47%)
USD |
NASDAQ |
Jun 28, 16:00
75.85
+0.01
(+0.01%)
After-Hours: 20:00
Nuvalent Free Cash Flow: -111.41M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -111.41M |
| December 31, 2023 | -99.74M |
| September 30, 2023 | -87.31M |
| June 30, 2023 | -82.50M |
| March 31, 2023 | -75.84M |
| December 31, 2022 | -64.97M |
| September 30, 2022 | -60.15M |
| Date | Value |
|---|---|
| June 30, 2022 | -53.37M |
| March 31, 2022 | -47.61M |
| December 31, 2021 | -40.00M |
| September 30, 2021 | -31.98M |
| June 30, 2021 | -24.65M |
| March 31, 2021 | -17.89M |
| December 31, 2020 | -14.95M |
Free Cash Flow Range, Past 5 Years
-111.41M
Minimum
Mar 2024
-14.95M
Maximum
Dec 2020
-58.03M
Average
-56.76M
Median
Free Cash Flow Benchmarks
| Phathom Pharmaceuticals Inc | -168.39M |
| Vera Therapeutics Inc | -99.72M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.09M |
| Cash from Investing (Quarterly) | -206.77M |
| Cash from Financing (Quarterly) | 5.986M |
| Free Cash Flow Per Share (Quarterly) | -0.5625 |
| Free Cash Flow Yield | -2.44% |